Molitch, Mark E.
303  Ergebnisse:
Personensuche X
?
 
?
3

Effects of metformin and intensive lifestyle interventions ..:

Molitch, Mark E. ; Tripputi, Mark ; Levey, Andrew S....
Journal of Diabetes and its Complications.  37 (2023)  9 - p. 108556 , 2023
 
?
 
?
 
?
7

RF13 | PMON159 Long-term Efficacy and Safety Data for Oral ..:

Fleseriu, Maria ; Molitch, Mark E ; Dreval, Alexander...
Journal of the Endocrine Society.  6 (2022)  Supplement_1 - p. A581-A582 , 2022
 
?
8

Management of Diabetes Mellitus in Patients With CKD: Core ..:

Hahr, Allison J. ; Molitch, Mark E.
American Journal of Kidney Diseases.  79 (2022)  5 - p. 728-736 , 2022
 
?
9

Hyperprolactinemia and Preconception Management:

, In: Pituitary Disorders throughout the Life Cycle,
Huang, Wenyu ; Molitch, Mark E. - p. 111-123 , 2022
 
?
10

LBMON178 2nd Year Outcomes Of The Open-label Extension Of C..:

Samson, Susan ; Nachtigall, Lisa ; Fleseriu, Maria...
Journal of the Endocrine Society.  6 (2022)  Supplement_1 - p. A474-A474 , 2022
 
?
11

Glucocorticoid receptor blockers:

Molitch, Mark E.
Pituitary.  25 (2022)  5 - p. 733-736 , 2022
 
?
12

PMON166 Safety Comparison of 40- vs 60-mg/day Doses of Oral..:

Elenkova, Atanaska ; Jensterle, Mojca ; Kennedy, Laurence...
Journal of the Endocrine Society.  6 (2022)  Supplement_1 - p. A547-A548 , 2022
 
?
13

Durable biochemical response and safety with oral octreotid..:

Samson, Susan L ; Nachtigall, Lisa B ; Fleseriu, Maria...
European Journal of Endocrinology.  187 (2022)  6 - p. 733-741 , 2022
 
?
15

A Phase 3 Large International Noninferiority Trial (MPOWERE..:

Fleseriu, Maria ; Dreval, Alexander V ; Pokramovich, Yulia...
Journal of the Endocrine Society.  5 (2021)  Supplement_1 - p. A517-A517 , 2021
 
1-15